Detecting anomalies in a deliberately biased tomotherapy plan: Comparison of two patient-specific quality assurance processes involving ArcCHECK and Gafchromic EBT3 films.

Fiche publication

Date publication

décembre 2017

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Auteurs

Membres identifiés du Cancéropôle Est :
Dr MEYER Philippe

Tous les auteurs :
Werlé F, Dehaynin N, Niederst C, Jarnet D, Gantier M, Karamanoukian D, Meyer P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28780318

Résumé

This work proposes a comparative evaluation of two of our patient-specific quality assurance processes involving ArcCHECK (Sun Nuclear) and Gafchromic EBT3 films (Ashland) in order to determine which detector is able to most effectively detect an anomaly in a deliberately biased tomotherapy plan.